A 5-week low-dose prednisolone regimen for progressive vitiligo: efficacy and safety in a single-center cohort study
This 5-week low-dose prednisolone regimen rapidly stabilizes progressive vitiligo across ages and subtypes, with high efficacy, minimal adverse effects, and excellent patient compliance. It offers a practical alternative to prolonged steroid protocols, particularly for early intervention.
Authors
- Yue‐Tong Qian (ORCID: https://orcid.org/0000-0001-9066-019X)
- Dong‐Lai Ma (ORCID: https://orcid.org/0000-0003-3703-5015)
- Jiawei Liu
Institutions
- Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
- Peking Union Medical College Hospital (CN)
Publication Details
- Journal
- Annals of Medicine
- Published
- 2025-09-01
- DOI
- https://doi.org/10.1080/07853890.2025.2543523
- Primary Topic
- melanin and skin pigmentation
- Type
- article
- Field-Weighted Citation Impact
- 0.00